Trial Outcomes & Findings for Increased Physical Activity Through Mindfulness (NCT NCT02869854)

NCT ID: NCT02869854

Last Updated: 2025-04-16

Results Overview

Each individual will wear an activity monitor for 7 days. This will be done at baseline and after 6 months. The difference in the time of physical activity level was measured in minutes of activity during a week and then divided into percentages of sedentary time, light physical activity time and moderate to vigourous physical activity time, measured by activity monitor Actigraph (GT3X). In the analysis

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

88 participants

Primary outcome timeframe

Baseline ,6 months.

Results posted on

2025-04-16

Participant Flow

Participant milestones

Participant milestones
Measure
PAP Only
This group will follow the referral scheme for three months, and after this period they will leave new blood samples and answer surveys. They will get a new PAP with follow up after another 3 months. PAP: Physical Activity on Prescription, after 3 months a new prescription
Mindfulness Only
Mindfulness. This group will receive a group course in mindfulness during 8 weeks once a week, and with 20 minutes of daily personal training. Three and six months after inclusion they will answer a new set of surveys and fasting blood samples. Mindfulness: Mindfulness course during 8 weeks with 20 minutes mindfulness exercise each day
Combination of the Two Groups
Mindfulness and physical activity prescription. This group will get a combination of the two other groups. PAP will be prescribed during the first meeting and another one after 3 months. During the first 8 weeks once a week they will participate in a mindfulness training group and also preform 20 minutes of daily training. The same surveys as the other groups and fasting blood samples Mindfulness: Mindfulness course during 8 weeks with 20 minutes mindfulness exercise each day PAP: Physical Activity on Prescription, after 3 months a new prescription
Overall Study
STARTED
29
30
29
Overall Study
COMPLETED
16
19
19
Overall Study
NOT COMPLETED
13
11
10

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Increased Physical Activity Through Mindfulness

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
PAP Only
n=29 Participants
This group will follow the referral scheme for three months, and after this period they will leave new blood samples and answer surveys. They will get a new PAP with follow up after another 3 months. PAP: Physical Activity on Prescription, after 3 months a new prescription
Mindfulness Only
n=30 Participants
Mindfulness. This group will receive a group course in mindfulness during 8 weeks once a week, and with 20 minutes of daily personal training. Three and six months after inclusion they will answer a new set of surveys and fasting blood samples. Mindfulness: Mindfulness course during 8 weeks with 20 minutes mindfulness exercise each day
Combination of the Two Groups
n=29 Participants
Mindfulness and physical activity prescription. This group will get a combination of the two other groups. PAP will be prescribed during the first meeting and another one after 3 months. During the first 8 weeks once a week they will participate in a mindfulness training group and also preform 20 minutes of daily training. The same surveys as the other groups and fasting blood samples Mindfulness: Mindfulness course during 8 weeks with 20 minutes mindfulness exercise each day PAP: Physical Activity on Prescription, after 3 months a new prescription
Total
n=88 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Categorical
Between 18 and 65 years
29 Participants
n=5 Participants
30 Participants
n=7 Participants
29 Participants
n=5 Participants
88 Participants
n=4 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Continuous
54 years
n=5 Participants
53 years
n=7 Participants
54 years
n=5 Participants
54 years
n=4 Participants
Sex: Female, Male
Female
22 Participants
n=5 Participants
22 Participants
n=7 Participants
20 Participants
n=5 Participants
64 Participants
n=4 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
8 Participants
n=7 Participants
9 Participants
n=5 Participants
24 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
29 Participants
n=5 Participants
30 Participants
n=7 Participants
29 Participants
n=5 Participants
88 Participants
n=4 Participants

PRIMARY outcome

Timeframe: Baseline ,6 months.

Population: Baseline and 6 months follow-up after inclusion. Change in percentage of sedentary time and time in different intensity of physical activity per valid day and averaged over the number of valid days, activity monitor measured

Each individual will wear an activity monitor for 7 days. This will be done at baseline and after 6 months. The difference in the time of physical activity level was measured in minutes of activity during a week and then divided into percentages of sedentary time, light physical activity time and moderate to vigourous physical activity time, measured by activity monitor Actigraph (GT3X). In the analysis

Outcome measures

Outcome measures
Measure
PAP Only
n=29 Participants
This group will follow the referral scheme for three months, and after this period they will leave new blood samples and answer surveys. They will get a new PAP with follow up after another 3 months. PAP: Physical Activity on Prescription, after 3 months a new prescription
Mindfulness Only
n=30 Participants
Mindfulness. This group will receive a group course in mindfulness during 8 weeks once a week, and with 20 minutes of daily personal training. Three and six months after inclusion they will answer a new set of surveys and fasting blood samples. Mindfulness: Mindfulness course during 8 weeks with 20 minutes mindfulness exercise each day
Combination of the Two Groups
n=29 Participants
Mindfulness and physical activity prescription. This group will get a combination of the two other groups. PAP will be prescribed during the first meeting and another one after 3 months. During the first 8 weeks once a week they will participate in a mindfulness training group and also preform 20 minutes of daily training. The same surveys as the other groups and fasting blood samples Mindfulness: Mindfulness course during 8 weeks with 20 minutes mindfulness exercise each day PAP: Physical Activity on Prescription, after 3 months a new prescription
Difference in Percentage of Time Spent Per Physical Activity Level Per Week of Time, Between the Three Different Groups Measured by Activity Monitor Actigraph (GT3X)
6 months Percent of LIPA
32.0 percentage of time
Standard Deviation 5.8
31.6 percentage of time
Standard Deviation 9.0
32.8 percentage of time
Standard Deviation 8.9
Difference in Percentage of Time Spent Per Physical Activity Level Per Week of Time, Between the Three Different Groups Measured by Activity Monitor Actigraph (GT3X)
Baseline:Percent of time in sedentary time
66.2 percentage of time
Standard Deviation 6.7
65.5 percentage of time
Standard Deviation 9.2
66.7 percentage of time
Standard Deviation 8.8
Difference in Percentage of Time Spent Per Physical Activity Level Per Week of Time, Between the Three Different Groups Measured by Activity Monitor Actigraph (GT3X)
Baseline:Percent of time in LIPA
30.9 percentage of time
Standard Deviation 6.2
31.7 percentage of time
Standard Deviation 8.2
30.3 percentage of time
Standard Deviation 8.0
Difference in Percentage of Time Spent Per Physical Activity Level Per Week of Time, Between the Three Different Groups Measured by Activity Monitor Actigraph (GT3X)
Baseline:Percent of time in MVPA
2.6 percentage of time
Standard Deviation 0.18
2.3 percentage of time
Standard Deviation 0.02
2.4 percentage of time
Standard Deviation 0.02
Difference in Percentage of Time Spent Per Physical Activity Level Per Week of Time, Between the Three Different Groups Measured by Activity Monitor Actigraph (GT3X)
6 months:Percent of time in sedentary time
65.0 percentage of time
Standard Deviation 6.8
65.9 percentage of time
Standard Deviation 9.4
64.0 percentage of time
Standard Deviation 9.1
Difference in Percentage of Time Spent Per Physical Activity Level Per Week of Time, Between the Three Different Groups Measured by Activity Monitor Actigraph (GT3X)
6 months: Percent of MVPA
2.6 percentage of time
Standard Deviation 0.02
1.9 percentage of time
Standard Deviation 0.02
2.7 percentage of time
Standard Deviation 0.02

SECONDARY outcome

Timeframe: base-line ,3 months, 6 months

Population: The number decreases during the study due to dropout, lost to follow-up.

assessment based on terms of perceived health with five alternative answers, a higher score incdicates a better outcome 1. very poor 2. poor 3. fair 4. good 5. very good

Outcome measures

Outcome measures
Measure
PAP Only
n=29 Participants
This group will follow the referral scheme for three months, and after this period they will leave new blood samples and answer surveys. They will get a new PAP with follow up after another 3 months. PAP: Physical Activity on Prescription, after 3 months a new prescription
Mindfulness Only
n=30 Participants
Mindfulness. This group will receive a group course in mindfulness during 8 weeks once a week, and with 20 minutes of daily personal training. Three and six months after inclusion they will answer a new set of surveys and fasting blood samples. Mindfulness: Mindfulness course during 8 weeks with 20 minutes mindfulness exercise each day
Combination of the Two Groups
n=29 Participants
Mindfulness and physical activity prescription. This group will get a combination of the two other groups. PAP will be prescribed during the first meeting and another one after 3 months. During the first 8 weeks once a week they will participate in a mindfulness training group and also preform 20 minutes of daily training. The same surveys as the other groups and fasting blood samples Mindfulness: Mindfulness course during 8 weeks with 20 minutes mindfulness exercise each day PAP: Physical Activity on Prescription, after 3 months a new prescription
Difference Between the Three Groups in Revised Assessment of Their Self-rated Health
Baseline
3 score on a scale
Interval 1.0 to 4.0
3 score on a scale
Interval 2.0 to 5.0
3 score on a scale
Interval 2.0 to 5.0
Difference Between the Three Groups in Revised Assessment of Their Self-rated Health
3 months
3 score on a scale
Interval 1.0 to 4.0
3 score on a scale
Interval 2.0 to 5.0
4 score on a scale
Interval 2.0 to 5.0
Difference Between the Three Groups in Revised Assessment of Their Self-rated Health
6 months
4 score on a scale
Interval 1.0 to 4.0
4 score on a scale
Interval 2.0 to 5.0
4 score on a scale
Interval 2.0 to 5.0

SECONDARY outcome

Timeframe: Baseline, 3 months, 6 months

Population: decreasing numbers due to drop-out

Insomnia Severity Index(ISI); is a self-report questionnaire measuring insomnia symptoms to evaluate the degree of insomnia. The scale consists of seven questions that evaluate Sleep mode, sleep during the night, waking up early, the feeling of being rested, how sleeping problems affect daily life, and how sleep patterns concern the individual. The higher the score, the better the outcome. Minimun score = 0, Maximum score = 28

Outcome measures

Outcome measures
Measure
PAP Only
n=29 Participants
This group will follow the referral scheme for three months, and after this period they will leave new blood samples and answer surveys. They will get a new PAP with follow up after another 3 months. PAP: Physical Activity on Prescription, after 3 months a new prescription
Mindfulness Only
n=30 Participants
Mindfulness. This group will receive a group course in mindfulness during 8 weeks once a week, and with 20 minutes of daily personal training. Three and six months after inclusion they will answer a new set of surveys and fasting blood samples. Mindfulness: Mindfulness course during 8 weeks with 20 minutes mindfulness exercise each day
Combination of the Two Groups
n=29 Participants
Mindfulness and physical activity prescription. This group will get a combination of the two other groups. PAP will be prescribed during the first meeting and another one after 3 months. During the first 8 weeks once a week they will participate in a mindfulness training group and also preform 20 minutes of daily training. The same surveys as the other groups and fasting blood samples Mindfulness: Mindfulness course during 8 weeks with 20 minutes mindfulness exercise each day PAP: Physical Activity on Prescription, after 3 months a new prescription
Difference Between Groups in the Amount of Self-perceived Sleep Problems
Insomnia Severity Index baseline
8 score on a scale
Interval 0.0 to 24.0
11 score on a scale
Interval 0.0 to 27.0
10 score on a scale
Interval 0.0 to 21.0
Difference Between Groups in the Amount of Self-perceived Sleep Problems
Insomnia Severity Index 3 months
7 score on a scale
Interval 0.0 to 20.0
11 score on a scale
Interval 0.0 to 27.0
9 score on a scale
Interval 0.0 to 27.0
Difference Between Groups in the Amount of Self-perceived Sleep Problems
Insomnia Severity Index 6 months
6 score on a scale
Interval 0.0 to 18.0
13 score on a scale
Interval 0.0 to 25.0
9 score on a scale
Interval 0.0 to 18.0

Adverse Events

PAP Only

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Mindfulness Only

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Combination of the Two Groups

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Mr Peter Nymberg

RegionSkane

Phone: 0705759810

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place